Aprepitant

This classification denotes an antiemetic agent with the molecular formula C23H21F7N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1NF15YR6UY, chemically known as 3h-1,2,4-triazol-3-one, 5-(((2r,3s)-2-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro- but generally known as aprepitant, which bears US NIH Compound Identifier 151165. European Medicines Agency schedules Aprepitant in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20017. The term APREPITANT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 3-4, 2001, List 46). World Health Organization schedules aprepitant in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule aprepitant under HS 29349990 and SITC 51579. As of Q4 2014, APREPITANT remains the US FDA Preferred Term for this commodity. Aprepitant bears US NLM identifiers UMLS ID C1176306 and NCI Concept Code C49173. SMILES: FC1CCC(C2N(CCOC2OC(C2CC(CC(C2)C(F)(F)F)C(F)(F)F)C)CC2[NH][NH]C(=O)N2)CC1.